Moderna
MRNA
MRNA
890 hedge funds and large institutions have $28.1B invested in Moderna in 2024 Q1 according to their latest regulatory filings, with 108 funds opening new positions, 328 increasing their positions, 292 reducing their positions, and 80 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
2% more funds holding
Funds holding: 874 → 890 (+16)
0.14% more ownership
Funds ownership: 68.54% → 68.68% (+0.14%)
27% less funds holding in top 10
Funds holding in top 10: 11 → 8 (-3)
Holders
890
Holding in Top 10
8
Calls
$1.61B
Puts
$1.32B
Top Buyers
| 1 | +$768M | |
| 2 | +$547M | |
| 3 | +$88.5M | |
| 4 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$83.1M |
| 5 |
UBS AM
Chicago,
Illinois
|
+$73.3M |
Top Sellers
| 1 | -$350M | |
| 2 | -$326M | |
| 3 | -$173M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$116M |
| 5 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$106M |